10,000-Person study to track how obesity drugs really work
NCT ID NCT07598981
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry will follow 10,000 people with obesity who are taking or starting standard weight-loss medications. Researchers will collect data on how well the drugs work and any side effects over time. The goal is to understand the real-world benefits and risks of these treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide real-world data on how well obesity medications work and their long-term safety.
- What could go wrong
- As an observational study, it cannot prove cause and effect. Results may be influenced by factors like patient selection or missing data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?